Common Contracts
7 similar Separation Agreement and Release contracts by Proteostasis Therapeutics, Inc.
CONFIDENTIALSeparation Agreement and Release • March 8th, 2019 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
CONFIDENTIALSeparation Agreement and Release • March 8th, 2019 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
CONFIDENTIALSeparation Agreement and Release • March 14th, 2018 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
October 21, 2016 Re:Amended and Restated Employment Agreement Dear Po-Shun:Separation Agreement and Release • November 10th, 2016 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Re: Employment AgreementSeparation Agreement and Release • August 8th, 2016 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This letter agreement (the “Agreement”) outlines the terms of your employment in your role as Chief Financial Officer of Proteostasis Therapeutics, Inc. (“Proteostasis” or the “Company”).
CONFIDENTIAL March 11, 2016 Po-Shun Lee, M.D.Separation Agreement and Release • March 16th, 2016 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Re: Employment AgreementSeparation Agreement and Release • March 16th, 2016 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
The Board of Directors has recently reviewed the terms and conditions of your employment and is pleased to provide this letter agreement (the “Agreement”) modifying the terms of your employment in your continuing role as President and Chief Executive Officer of Proteostasis Therapeutics, Inc. (“Proteostasis” or the “Company”). This Agreement amends, restates, and supersedes in its entirety the letter agreement dated April 4, 2014 between you and the Company (the “Offer Letter Agreement”). This Agreement is effective as of the date hereof.
